Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29
Guns for Domestic Abusers, Agency Power Next Up at Supreme Court
The Supreme Court is already planning to dive back into the culture wars and tackle the power of
2023-07-02 23:48
Everything to Know About Aspartame as WHO Prepares to Flag Cancer Risk
The World Health Organization will declare one of the world’s most widely used artificial sweeteners, found in thousands
2023-06-30 13:52
US FDA Uncovers Fresh Faults at India’s Second-Biggest Drugmaker
US Food and Drug Administration officials found multiple faults at a plant run by one of India’s biggest
2023-06-30 05:27
Ipsen Gets FDA Advisers’ Backing for Rare Bone Disease Drug
Ipsen SA’s drug for a rare bone disease got support from a panel of US drug regulatory advisers,
2023-06-29 15:17
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:21
World Health Organization to Assess Cancer Risk of Diet-Soda Sweetener Aspartame
The World Health Organization is planning to release two new reports on the safety of aspartame, the popular
2023-06-23 22:45
GSK Settles First Zantac Cancer Lawsuit Set for Trial in US
GSK Plc reached a settlement with a man who claimed the drugmaker’s blockbuster heartburn medication Zantac caused his
2023-06-23 14:54
Pfizer, GSK Shots for RSV Get Backing for Older Adults
Shots from Pfizer Inc. and GSK Plc that prevent respiratory syncytial virus got backing from a panel of
2023-06-22 05:57
Elon Musk Says He Has Improved ‘Corrosive’ Twitter for Most Users
Elon Musk, speaking at a conference in Paris, said that he bought Twitter Inc. because the social network
2023-06-17 01:58
Covid Boosters Should Be Updated to Target XBB Strain, US Health Advisers Say
Covid-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide
2023-06-16 04:46
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the
2023-06-12 09:22